加拿大菌血症病原体分布及抗菌药物敏感性:CANWARD研究(2007-2023)
CANWARD监测研究分析了2007至2023年加拿大医院血流分离菌的病原体分布和药敏特征。共26 067株血流分离菌,最常见为大肠埃希菌、金黄色葡萄球菌、肺炎克雷伯菌、表皮葡萄球菌和肺炎链球菌。病原体分布随时间变化不大,但产ESBL大肠埃希菌和肺炎克雷伯菌比例上升,粪肠球菌对万古霉素敏感性下降。
要点
- 17年间最常见血流病原体为大肠埃希菌、金黄色葡萄球菌和肺炎克雷伯菌。
- 产ESBL大肠埃希菌比例从4.5%(2007-09)升至12.7%(2019-23)。
- 粪肠球菌对万古霉素敏感性从84.9%(2007-09)降至69.0%(2019-23)。
核心结论
- 加拿大菌血症常见病原体分布17年来变化不大,但产ESBL大肠埃希菌、产ESBL肺炎克雷伯菌和VRE近年更常见。
研究设计与样本
- CANWARD监测研究每年从加拿大医院哨点实验室收集血流分离菌,2007至2023年共26 067株,其中住院患者14 954株、门诊患者11 107株。
- 采用肉汤微量稀释法进行抗菌药物敏感性试验。
主要发现
- 血流分离菌中最常见五种病原体为大肠埃希菌、金黄色葡萄球菌、肺炎克雷伯菌、表皮葡萄球菌和肺炎链球菌。
- 住院患者中更常见白色念珠菌、阴沟肠杆菌和铜绿假单胞菌,门诊患者中更常见化脓性链球菌和无乳链球菌。
- 产ESBL大肠埃希菌比例从4.5%(2007-09)升至12.7%(2019-23);产ESBL肺炎克雷伯菌从2.0%(2007-09)升至7.1%(2018-23)。
- 粪肠球菌对万古霉素敏感性从84.9%(2007-09)降至69.0%(2019-23)。
- MRSA和难治性耐药表型铜绿假单胞菌的比例相对稳定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Bloodstream infections are associated with significant morbidity and mortality. The purpose of this study was to determine the most common pathogens causing bacteraemia among Canadian patients and to evaluate their antimicrobial susceptibility profiles. METHODS: Annually from 2007 to 2023, bloodstream isolates from patients admitted to or evaluated at Canadian hospitals were collected by sentinel laboratories (CANWARD surveillance study). Antimicrobial susceptibility testing was performed by broth microdilution. RESULTS: In total, 26 067 bloodstream isolates were obtained over 17 years of the CANWARD study (14 954 from inpatients, 11 107 from outpatients, no patient location for six isolates). The five most common pathogens were Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Staphylococcus epidermidis and Streptococcus pneumoniae. There was little variation in pathogen distribution over time but certain pathogens were more common among inpatients (e.g. Candida albicans, Enterobacter cloacae, Pseudomonas aeruginosa) while others were more common among outpatients (e.g. Streptococcus pyogenes, Streptococcus agalactiae). The proportion of ESBL-producing E. coli increased from 4.5% (2007-09) to 12.7% (2019-23). The proportion of ESBL-producing K. pneumoniae increased from 2.0% (2007-09) to 7.1% (2018-23). Vancomycin susceptibility among Enterococcus faecium decreased from 84.9% (2007-09) to 69.0% (2019-23). In contrast, the proportions of S. aureus that were MRSA and P. aeruginosa that had a difficult-to-treat resistance phenotype were relatively stable. CONCLUSIONS: There has been little variation in the pathogens commonly causing bacteraemia among Canadian patients over the course of the CANWARD study, but some resistant phenotypes (e.g. ESBL-producing E. coli, ESBL-producing K. pneumoniae, VRE) are being encountered more frequently in recent years.
引用
- Walkty A, Adam HJ, Baxter M, et al. Distribution and antimicrobial susceptibility profile of pathogens recovered from the bloodstream of Canadian patients: results from the CANWARD study (2007-23). J Antimicrob Chemother. 2025. PMID: 40873027. doi:10.1093/jac/dkaf223
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。